Monika Ermann

Person

Abingdon, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Compounds for treatment of diseases related to DUX4 expression
- Patent number 10,973,820
- Issue date Apr 13, 2021
- Facio Intellectual Property B.V.
- Joris de Maeyer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicyclic tetrahydrothiazepine derivatives useful for the treatment...
- Patent number 10,472,341
- Issue date Nov 12, 2019
- Apeiron Biologics AG
- Monika Ermann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Deubiquitinase inhibitors and methods for use of the same
- Patent number 9,868,736
- Issue date Jan 16, 2018
- The Regents of the University of Michigan
- Nicholas J. Donato
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds which modulate the CB2 receptor
- Patent number 9,315,454
- Issue date Apr 19, 2016
- Boehringer Ingelheim International GmbH
- Alessandra Bartolozzi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Amine and ether compounds which modulate the CB2 receptor
- Patent number 8,957,063
- Issue date Feb 17, 2015
- Boehringer Ingelheim International GmbH
- Pier Francesco Cirillo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sulfonyl compounds which modulate the CB2 receptor
- Patent number 8,846,936
- Issue date Sep 30, 2014
- Boehringer Ingelheim International GmbH
- Eugene Richard Hickey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds which modulate the CB2 receptor
- Patent number 8,829,034
- Issue date Sep 9, 2014
- Boehringer Ingerlheim International GmbH
- Angela Berry
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds which selectively modulate the CB2 receptor
- Patent number 8,735,430
- Issue date May 27, 2014
- Boehringer Ingelheim International GmbH
- Alessandra Bartolozzi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds which selectively modulate the CB2 receptor
- Patent number 8,383,651
- Issue date Feb 26, 2013
- Boehringer Ingelheim International GmbH
- Alessandra Bartolozzi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds which selectively modulate the CB2 receptor
- Patent number 8,372,874
- Issue date Feb 12, 2013
- Boehringer Ingelheim International GmbH
- Alessandra Bartolozzi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic uses of compounds which selectively modulate the CB2 re...
- Patent number 8,362,039
- Issue date Jan 29, 2013
- Boehringer Ingelheim International GmbH
- Alessandra Bartolozzi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic uses of compounds which selectively modulate the CB2 re...
- Patent number 8,349,871
- Issue date Jan 8, 2013
- Boehringer Ingelheim International GmbH
- Alessandra Bartolozzi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrazole compounds which selectively modulate the CB2 receptor
- Patent number 8,329,735
- Issue date Dec 11, 2012
- Boehringer Ingelheim International GmbH
- Monika Ermann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds which modulate the CB2 receptor
- Patent number 8,299,111
- Issue date Oct 30, 2012
- Boehringer Ingelheim International GmbH
- Angela Berry
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds which selectively modulate the CB2 receptor
- Patent number 8,048,899
- Issue date Nov 1, 2011
- Boehringer Ingelheim International GmbH
- Alessandra Bartolozzi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds which modulate the CB2 receptor
- Patent number 7,935,715
- Issue date May 3, 2011
- Boehringer Ingelheim International GmbH
- Angela Berry
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds which modulate the CB2 receptor
- Patent number 7,928,123
- Issue date Apr 19, 2011
- Boehringer Ingelheim International GmbH
- Angela Berry
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds which modulate the CB2 receptor
- Patent number 7,595,397
- Issue date Sep 29, 2009
- Boehringer Ingelheim International GmbH
- Renee Zindell
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Compounds for treatment of diseases related to DUX4 expression
- Publication number 20220226318
- Publication date Jul 21, 2022
- Facio Intellectual Property B.V.
- Joris de Maeyer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds for treatment of diseases related to DUX4 expression
- Publication number 20210177847
- Publication date Jun 17, 2021
- Facio Intellectual Property B.V.
- Joris de Maeyer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds for treatment of diseases related to DUX4 expression
- Publication number 20190175596
- Publication date Jun 13, 2019
- Facio Intellectual Property B.V.
- Joris de Maeyer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BICYCLIC TETRAHYDROTHIAZEPINE DERIVATIVES USEFUL FOR THE TREATMENT...
- Publication number 20180170888
- Publication date Jun 21, 2018
- APEIRON BIOLOGICS AG
- Monika ERMANN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DEUBIQUITINASE INHIBITORS AND METHODS FOR USE OF THE SAME
- Publication number 20160237082
- Publication date Aug 18, 2016
- The Regents of the University of Michigan
- Nicholas J. Donato
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SULFONYL COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR
- Publication number 20130184315
- Publication date Jul 18, 2013
- Boehringer Ingelheim International GmbH
- Eugene Richard Hickey
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds Which Selectively Modulate The CB2 Receptor
- Publication number 20130030022
- Publication date Jan 31, 2013
- Boehringer Ingelheim International GmbH
- Alessandra BARTOLOZZI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR
- Publication number 20120316173
- Publication date Dec 13, 2012
- Boehringer Ingelheim International GmbH
- Alessandra Bartolozzi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Tetrazole Compounds Which Selectively Modulate The CB2 Receptor
- Publication number 20120071529
- Publication date Mar 22, 2012
- Boehringer Ingelheim International GmbH
- Monika ERMANN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Sulfone Compounds Which Modulate The CB2 Receptor
- Publication number 20120015988
- Publication date Jan 19, 2012
- Boehringer Ingelheim International GmbH
- Eugene Richard Hickey
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Therapeutic Uses of Compounds Which Selectively Modulate The CB2 Re...
- Publication number 20120010184
- Publication date Jan 12, 2012
- Boehringer Ingelheim International GmbH
- Alessandra BARTOLOZZI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Therapeutic Uses of Compounds Which Selectively Modulate The CB2 Re...
- Publication number 20110312932
- Publication date Dec 22, 2011
- Boehringer Ingelheim International GmbH
- Alessandra BARTOLOZZI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Amine and Ether Compounds Which Modulate The CB2 Receptor
- Publication number 20110190256
- Publication date Aug 4, 2011
- Boehringer Ingelheim International GmbH
- Pier Francesco Cirillo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds Which Selectively Modulate The CB2 Receptor
- Publication number 20110136869
- Publication date Jun 9, 2011
- Boehringer Ingelheim International GmbH
- Alessandra Bartolozzi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds Which Modulate The CB2 Receptor
- Publication number 20110130431
- Publication date Jun 2, 2011
- Boehringer Ingelheim International GmbH
- Angela BERRY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds Which Selectively Modulate The CB2 Receptor
- Publication number 20110071196
- Publication date Mar 24, 2011
- Boehringer Ingelheim International GmbH
- Alessandra BARTOLOZZI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds Which Modulate the CB2 Receptor
- Publication number 20110071127
- Publication date Mar 24, 2011
- Boehringer Ingelheim International GmbH
- Angela BERRY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Diazepane Compounds Which Modulate The CB2 Receptor
- Publication number 20100261708
- Publication date Oct 14, 2010
- Boehringer Ingelheim International GmbH
- Pier Francesco Cirillo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds Which Selectively Modulate The CB2 Receptor
- Publication number 20100081644
- Publication date Apr 1, 2010
- Boehringer Ingelheim International GmbH
- Alessandra BARTOLOZZI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds Which Selectively Modulate The CB2 Receptor
- Publication number 20100076029
- Publication date Mar 25, 2010
- Boehringer Ingelheim International GmbH
- Alessandra BARTOLOZZI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds which Modulate the CB2 Receptor
- Publication number 20080081822
- Publication date Apr 3, 2008
- Angela Berry
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds Which Modulate The CB2 Receptor
- Publication number 20080039464
- Publication date Feb 14, 2008
- Angela BERRY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds Which Modulate The CB2 Receptor
- Publication number 20070191340
- Publication date Aug 16, 2007
- Renee Zindell
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted heterocyclic compounds and methods of use
- Publication number 20050070554
- Publication date Mar 31, 2005
- Amgen Inc.
- Joseph J. Nunes
- C07 - ORGANIC CHEMISTRY

Monika Ermann

Person

Patents Grantslast 30 patents

Compounds for treatment of diseases related to DUX4 expression

Bicyclic tetrahydrothiazepine derivatives useful for the treatment...

Deubiquitinase inhibitors and methods for use of the same

Compounds which modulate the CB2 receptor

Amine and ether compounds which modulate the CB2 receptor

Sulfonyl compounds which modulate the CB2 receptor

Compounds which modulate the CB2 receptor

Compounds which selectively modulate the CB2 receptor

Compounds which selectively modulate the CB2 receptor

Compounds which selectively modulate the CB2 receptor

Therapeutic uses of compounds which selectively modulate the CB2 re...

Therapeutic uses of compounds which selectively modulate the CB2 re...

Tetrazole compounds which selectively modulate the CB2 receptor

Compounds which modulate the CB2 receptor

Compounds which selectively modulate the CB2 receptor

Compounds which modulate the CB2 receptor

Compounds which modulate the CB2 receptor

Compounds which modulate the CB2 receptor

Patents Applicationslast 30 patents

Compounds for treatment of diseases related to DUX4 expression

Compounds for treatment of diseases related to DUX4 expression

Compounds for treatment of diseases related to DUX4 expression

BICYCLIC TETRAHYDROTHIAZEPINE DERIVATIVES USEFUL FOR THE TREATMENT...

DEUBIQUITINASE INHIBITORS AND METHODS FOR USE OF THE SAME

SULFONYL COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR

Compounds Which Selectively Modulate The CB2 Receptor

COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR

Tetrazole Compounds Which Selectively Modulate The CB2 Receptor

Sulfone Compounds Which Modulate The CB2 Receptor

Therapeutic Uses of Compounds Which Selectively Modulate The CB2 Re...

Therapeutic Uses of Compounds Which Selectively Modulate The CB2 Re...

Amine and Ether Compounds Which Modulate The CB2 Receptor

Compounds Which Selectively Modulate The CB2 Receptor

Compounds Which Modulate The CB2 Receptor

Compounds Which Selectively Modulate The CB2 Receptor

Compounds Which Modulate the CB2 Receptor

Diazepane Compounds Which Modulate The CB2 Receptor

Compounds Which Selectively Modulate The CB2 Receptor

Compounds Which Selectively Modulate The CB2 Receptor

Compounds which Modulate the CB2 Receptor

Compounds Which Modulate The CB2 Receptor

Compounds Which Modulate The CB2 Receptor

Substituted heterocyclic compounds and methods of use